Henry E Wang1, Russell Griffin2, Nathan I Shapiro3, George Howard4, Monika M Safford5. 1. Department of Emergency Medicine, University of Alabama School of Medicine, Birmingham, AL, USA hwang@uabmc.edu. 2. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA. 3. Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. 4. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Division of Preventive Medicine, Department of Medicine, University of Alabama School of Medicine, Birmingham, AL, USA.
Abstract
PURPOSE: "Statins" have immunomodulatory and anti-inflammatory effects and may attenuate the risk of infections. We sought to determine the association between chronic statin use and long-term rates of sepsis events. MATERIALS AND METHODS: We used data from 30 183 adult (≥45 years old) community-dwelling participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. The primary exposure was statin use. The primary outcome was hospitalization or emergency department treatment for sepsis. Using Cox proportional hazards models, we determined associations between statin use and first sepsis events, adjusting for patients demographics, health behaviors, chronic medical conditions, degree of medication adherence, baseline high-sensitivity C-reactive protein (hsCRP), and propensity for statin use. RESULTS: Approximately one-third of participants reported statin use (n = 9475, 31.4%). During the 10-year follow-up period from 2003 to 2012, there were 1500 incident sepsis events. Statin use was not associated with rates of sepsis after multivariable adjustment for demographics, health behaviors, chronic medical conditions, medication adherence, abnormal hsCRP, and propensity for statin use, hazard ratio 0.93 (95% confidence interval: 0.81-1.06). Statin use was not similarly associated with rates of sepsis when stratified by propensity for statin use or medication adherence. CONCLUSION: In the REGARDS cohort, statin use at baseline was not associated with rates of future sepsis events.
PURPOSE: "Statins" have immunomodulatory and anti-inflammatory effects and may attenuate the risk of infections. We sought to determine the association between chronic statin use and long-term rates of sepsis events. MATERIALS AND METHODS: We used data from 30 183 adult (≥45 years old) community-dwelling participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. The primary exposure was statin use. The primary outcome was hospitalization or emergency department treatment for sepsis. Using Cox proportional hazards models, we determined associations between statin use and first sepsis events, adjusting for patients demographics, health behaviors, chronic medical conditions, degree of medication adherence, baseline high-sensitivity C-reactive protein (hsCRP), and propensity for statin use. RESULTS: Approximately one-third of participants reported statin use (n = 9475, 31.4%). During the 10-year follow-up period from 2003 to 2012, there were 1500 incident sepsis events. Statin use was not associated with rates of sepsis after multivariable adjustment for demographics, health behaviors, chronic medical conditions, medication adherence, abnormal hsCRP, and propensity for statin use, hazard ratio 0.93 (95% confidence interval: 0.81-1.06). Statin use was not similarly associated with rates of sepsis when stratified by propensity for statin use or medication adherence. CONCLUSION: In the REGARDS cohort, statin use at baseline was not associated with rates of future sepsis events.
Authors: B M Psaty; T D Koepsell; D Lin; N S Weiss; D S Siscovick; F R Rosendaal; M Pahor; C D Furberg Journal: J Am Geriatr Soc Date: 1999-06 Impact factor: 5.562
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Nathan I Shapiro; Richard E Wolfe; Richard B Moore; Eric Smith; Elizabeth Burdick; David W Bates Journal: Crit Care Med Date: 2003-03 Impact factor: 7.598
Authors: Hendrik Schmidt; Ralf Hennen; Alexander Keller; Martin Russ; Ursula Müller-Werdan; Karl Werdan; Michael Buerke Journal: Intensive Care Med Date: 2006-06-21 Impact factor: 17.440
Authors: Julian M Williams; Jaimi H Greenslade; Kevin Chu; Anthony F T Brown; David Paterson; Jeffrey Lipman Journal: Acad Emerg Med Date: 2011-02 Impact factor: 3.451
Authors: Michael W Donnino; Michael N Cocchi; Michael Howell; Peter Clardy; Daniel Talmor; Lauren Cataldo; Maureen Chase; Adel Al-Marshad; Long Ngo; Nathan I Shapiro Journal: Acad Emerg Med Date: 2009-03 Impact factor: 3.451
Authors: Reimar W Thomsen; Heidi H Hundborg; Søren P Johnsen; Lars Pedersen; Henrik T Sørensen; Henrik C Schønheyder; Hans-Henrik Lervang Journal: Crit Care Med Date: 2006-04 Impact factor: 7.598
Authors: Ninad S Chaudhary; John P Donnelly; Justin X Moore; John W Baddley; Monika M Safford; Henry E Wang Journal: Crit Care Date: 2017-07-13 Impact factor: 9.097
Authors: Justin Xavier Moore; Tomi Akinyemiju; Alfred Bartolucci; Henry E Wang; John Waterbor; Russell Griffin Journal: J Intensive Care Med Date: 2018-06-03 Impact factor: 3.510
Authors: Faheem W Guirgis; John P Donnelly; Sunita Dodani; George Howard; Monika M Safford; Emily B Levitan; Henry E Wang Journal: Crit Care Date: 2016-12-23 Impact factor: 9.097